Skip to main content
PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
70.26
+1.04 (1.50%)
At close: Apr 28, 2026, 4:00 PM EDT
70.26
0.00 (0.00%)
Pre-market: Apr 29, 2026, 4:06 AM EDT

PTC Therapeutics Revenue by Segment
Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Collaboration
998.36M 998.73M 989.48M 986.54M 304.00K - - -
Collaboration Growth
328,306.91% - - - -99.70% - - -
Net Product
586.70M 557.42M 561.88M 576.77M 600.95M 601.31M 609.92M 651.30M
Net Product Growth
-2.37% -7.30% -7.88% -11.44% -9.12% -5.11% -2.23% 9.84%
Royalty
244.22M 223.00M 213.57M 209.15M 203.86M 196.70M 185.51M 169.18M
Royalty Growth
19.80% 13.37% 15.13% 23.63% 20.73% 24.71% 32.05% 34.85%
Manufacturing
-98.63M - - - - - 5.00M 7.06M
Manufacturing Growth
- - - - - - 14.85% 255.08%

Revenue by Product
Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Translarna
235.30M 290.17M 311.80M 322.70M 340.30M 321.50M 318.20M 344.30M
Translarna Growth
-30.86% -9.75% -2.01% -6.27% -4.36% -4.43% -7.50% 6.10%
Emflaza
146.36M 169.56M 186.30M 197.20M 206.70M 224.10M 239.60M 258.00M
Emflaza Growth
-29.19% -24.34% -22.25% -23.57% -18.97% -8.83% 2.74% 15.02%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.